Details for Patent: 7,737,282
✉ Email this page to a colleague
Title: | Benzimidazole compound crystal |
Abstract: | A novel crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-- 1H-benzimidazole or a salt thereof of the present invention is useful for an excellent antiulcer agent. |
Inventor(s): | Fujishima; Akira (Hyogo, JP), Aoki; Isao (Hyogo, JP), Kamiyama; Keiji (Osaka, JP) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Filing Date: | Feb 26, 2009 |
Application Number: | 12/393,409 |
Claims: | 1. An amorphous compound of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-- 1H-benzimidazole or a salt thereof. 2. A pharmaceutical composition comprising the amorphous compound according to claim 1 and a pharmaceutically acceptable excipient, carrier or diluent. 3. A pharmaceutical composition according to claim 2, wherein the pharmaceutical composition includes an effective amount of the amorphous compound to treat or prevent digestive ulcer. 4. A method for treating or preventing digestive ulcer, which comprises administering to a mammal in need thereof an effective amount of the amorphous compound of claim 1. |